Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Neil Osterweil

    Video

    Gut bacteria influence HCT outcomes

    Author:
    Neil Osterweil
    Publish date: December 2, 2018

    SAN DIEGO – Gut microbiome diversity predicts overall survival after hematopoietic cell transplant.

    • Read More

    News

    JULIET: CAR T cells keep trucking against DLBCL

    Author:
    Neil Osterweil
    Publish date: December 2, 2018

    SAN DIEGO – Median overall survival for patients with complete responses to CAR T-cell therapy was not reached through 19 months of follow-up.

    • Read More

    News

    FLYER: Four cycles of R-CHOP as good as six in low-risk DLBCL

    Author:
    Neil Osterweil
    Publish date: December 1, 2018

    SAN DIEGO – Survival outcomes were nearly identical and adverse events were lower with four versus six cycles of R-CHOP in patients with favorable...

    • Read More

    Video

    FLYER: R-CHOP 4 safer, as effective for low-risk DLBCL patients under 60

    Author:
    Neil Osterweil
    Publish date: December 1, 2018

    SAN DIEGO – Progression-free, event-free, and overall survival were comparable with that of patients assigned to six cycles of therapy.

    • Read More

    News

    Sickle cell disease phenotype reversed by gene therapy

    Author:
    Neil Osterweil
    Publish date: December 1, 2018

    SAN DIEGO – Genetically modified autologous stem cells increased protective fetal hemoglobin and decreased sickle hemoglobin in an adult with...

    • Read More

    Video

    Flipping the fetal hemoglobin switch reverses sickle cell symptoms

    Author:
    Neil Osterweil
    Publish date: December 1, 2018

    SAN DIEGO – One adult with sickle cell disease had near-complete remission of symptoms after 6 months of follow-up.

    • Read More

    News

    Cortactin expression aids in CLL-MCL differential

    Author:
    Neil Osterweil
    Publish date: November 28, 2018

    Cortactin, a cytoskeleton-remodeling adapter protein, is expressed on most CLL cells, but not similar-appearing MCL cells.

    • Read More

    News

    ASH 2018 coming attractions look at the big picture

    Author:
    Neil Osterweil
    Publish date: November 21, 2018

    Big trials, big results in malignant and nonmalignant hematologic disorders are on the program at the 2018 ASH annual meeting.

    • Read More

    News

    BAP1 expression augurs prognosis of metastatic RCC

    Author:
    Neil Osterweil
    Publish date: November 19, 2018

    Discordant gene expression results between primary tumors and metastases reveal a need for prognostic biomarkers in metastases.

    • Read More

    News

    PD-L1 correlates with worse sporadic, hereditary ccRCC outcomes

    Author:
    Neil Osterweil
    Publish date: November 19, 2018

    Patients with sporadic clear cell renal cell carcinomas expressing PD-L1 had worse disease-free survival.

    • Read More

    News

    R-CHOP effective as first-line treatment in FL

    Author:
    Neil Osterweil
    Publish date: November 16, 2018

    Long-term data suggest R-CHOP can be effective as first-line treatment for patients with follicular lymphoma (FL). In a phase 2-3 trial,...

    • Read More

    News

    R-CHOP looks viable as first line in follicular lymphoma

    Author:
    Neil Osterweil
    Publish date: November 15, 2018

    Long-term follow-up of a randomized trial showed durable efficacy of R-CHOP with no increase in histological transformation or secondary cancers...

    • Read More

    News

    Preoperative anemia management saves blood, money

    Author:
    Neil Osterweil
    Publish date: November 15, 2018

    BOSTON—Results of a pilot program suggest preoperative management of anemia can reduce transfusion rates and cut costs, but the effect on patient...

    • Read More

    News

    Preop anemia management saves blood, costs

    Author:
    Neil Osterweil
    Publish date: November 14, 2018

    BOSTON – Managing anemia prior to cardiac surgery saved a hospital more than $100,000 in transfusion costs in a pilot program.

    • Read More

    News

    ADAR1 linked to MM pathogenesis, outcomes

    Author:
    Neil Osterweil
    Publish date: November 14, 2018

    Overly zealous editing of messenger RNA in multiple myeloma (MM) cells contributes to MM pathogenesis and is associated with poor outcomes after...

    • Read More

    Pages

    • « first
    • …
    • 32
    • 33
    • 34
    • 35
    • 36
    • 37
    • 38
    • 39
    • 40
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery